Muchos estadounidenses han recurrido a la 煤ltima gran idea para perder peso; ya sean dietas de moda, la obsesi贸n por el fitness, hierbas y p铆ldoras poco fiables o la cirug铆a bari谩trica. Parece que nunca acaban siendo la soluci贸n m谩gica con la que la gente sue帽a.
Patients Complain Some Obesity Care Startups Offer Pills, and Not Much Else
A new wave of obesity care startups offer access to new weight loss medications. But do they offer good health care?
You may have seen the ads that promise weight loss and better health 鈥 phone apps, rings, and other devices 鈥 by giving you data on how your body reacts to food, exercise, and sleep. Is this information enough to help consumers achieve their goals?
La nueva generaci贸n de medicamentos para la p茅rdida de peso es prometedora, pero tiene un precio
Algunos pacientes, seg煤n los especialistas en medicina de la obesidad, experimentan una disminuci贸n de la presi贸n arterial, un mejor control de la diabetes, menos dolor en las articulaciones y un mejor sue帽o gracias a estos nuevos tratamientos.
脥ndice de masa corporal: una medida err贸nea del peso que afecta el tratamiento de la obesidad
Los tratamientos actuales para la obesidad y los trastornos alimentarios, y sus costos, muchas veces se basan en esta medida que no est谩 amparada en la ciencia.
BMI: The Mismeasure of Weight and the Mistreatment of Obesity
The human body mass index 鈥 a simple mathematical equation 鈥 is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.
New Weight Loss Treatment Is Marked by Heavy Marketing and Modest Results
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person鈥檚 stomach, to help people eat less. Results vary widely but are modest on average.
Diabetes Drug鈥檚 New Weight Loss Formula Fuels Cost-Benefit Debate
Health plans鈥 coverage of the medication, branded as Wegovy 鈥 which has a $1,300-a-month price tag 鈥 is not a sure thing.
